ERAL1 and breast carcinoma: Thus, together with other TFs such as Forkhead box protein A1 (FoxA1) and Activating enhancer binding Protein 2 γ (AP-2γ), the estrogen-independent activity of ERα seems important in maintaining the luminal epithelial phenotype and blocking EMT in breast cancer cells.